Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based...
marketwire.com     May 16, 2008            

First and Only Therapy Approved to Treat Both Type 2 Diabetes and High LDL-Cholesterol Welchol Recently Added to ACE/AACE Road Maps PARSIPPANY, NJ--(Marketwire - Daiichi Sankyo, Inc. (DSI) announced today that data from two pooled analyses further demonstrate that Welchol™ (colesevelam HCl), in... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Dr. Allan Moore dies at age 31

osu.edu     Jul 24, 2008   2 related          

At his bedside were his wife, Dr. Rebekah Gee, his parents, Dr. Michael A. and Janet Moore, and his father-in-law, Ohio State President E. Gordon Gee. A native of Danville, Va., Allan was a fellow in endocrinology and practiced...                

comments

New Recommendations For Prediabetes

cbsnews.com     Jul 24, 2008   5 related          

Doctors Recommend Lifestyle Changes And Medication If Needed: Don't Wait Until It Becomes Diabetes Liver Protein Linked to Diabetes Risk FDA Urged to Toughen Diabetes Drug Tests Diabetes and Weight Loss: Finding the Right Path...                

comments

                   

Research Says Get Pre-Diabetes Treatment Soon

emaxhealth.com     Jul 24, 2008   11 related          

Researchers suggest that pre-diabetes must be treated aggressively because if the treatment is not provided early it will cause health and financial problems later in life. American Association of Clinical Endocrinologists...                

comments

Ser1369Ala variant in sulphonylurea receptor gene ABCC8 is associated with antidiabetic efficacy...

biowizard.com     11 hrs ago          

Anhui Biomedical Institute, Anhui Medical University, Hefei, China. Objective- To investigate if genetic variants could influence antidiabetic efficacy of gliclazide in type 2 diabetes (T2D) patients. Research design and...                

comments